Logo image of XPER

XPERI INC (XPER) Stock Fundamental Analysis

NYSE:XPER - New York Stock Exchange, Inc. - US98423J1016 - Common Stock - Currency: USD

7.805  -0.06 (-0.7%)

Fundamental Rating

4

Overall XPER gets a fundamental rating of 4 out of 10. We evaluated XPER against 283 industry peers in the Software industry. XPER scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XPER has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year XPER was profitable.
In the past year XPER has reported a negative cash flow from operations.
In the past 5 years XPER always reported negative net income.
In the past 5 years XPER reported 4 times negative operating cash flow.
XPER Yearly Net Income VS EBIT VS OCF VS FCFXPER Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

The Return On Assets of XPER (-3.04%) is comparable to the rest of the industry.
With a Return On Equity value of -4.60%, XPER perfoms like the industry average, outperforming 59.01% of the companies in the same industry.
Industry RankSector Rank
ROA -3.04%
ROE -4.6%
ROIC N/A
ROA(3y)-41.72%
ROA(5y)-29.98%
ROE(3y)-66.84%
ROE(5y)-46.08%
ROIC(3y)N/A
ROIC(5y)N/A
XPER Yearly ROA, ROE, ROICXPER Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

XPER has a Gross Margin of 76.76%. This is in the better half of the industry: XPER outperforms 72.44% of its industry peers.
In the last couple of years the Gross Margin of XPER has declined.
XPER does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y-4.34%
XPER Yearly Profit, Operating, Gross MarginsXPER Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

XPER does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XPER has been increased compared to 1 year ago.
The number of shares outstanding for XPER has been reduced compared to 5 years ago.
Compared to 1 year ago, XPER has a worse debt to assets ratio.
XPER Yearly Shares OutstandingXPER Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
XPER Yearly Total Debt VS Total AssetsXPER Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.20, we must say that XPER is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of XPER (-0.20) is worse than 71.02% of its industry peers.
XPER has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
XPER has a Debt to Equity ratio of 0.10. This is comparable to the rest of the industry: XPER outperforms 55.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z -0.2
ROIC/WACCN/A
WACC11.13%
XPER Yearly LT Debt VS Equity VS FCFXPER Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

XPER has a Current Ratio of 2.27. This indicates that XPER is financially healthy and has no problem in meeting its short term obligations.
XPER has a Current ratio of 2.27. This is in the better half of the industry: XPER outperforms 66.78% of its industry peers.
XPER has a Quick Ratio of 2.26. This indicates that XPER is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.26, XPER is doing good in the industry, outperforming 66.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 2.26
XPER Yearly Current Assets VS Current LiabilitesXPER Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1172.73% over the past year.
Measured over the past years, XPER shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.24% on average per year.
The Revenue has decreased by -4.77% in the past year.
The Revenue has been growing by 20.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1172.73%
EPS 3Y-21.82%
EPS 5Y-21.24%
EPS Q2Q%420%
Revenue 1Y (TTM)-4.77%
Revenue growth 3Y0.49%
Revenue growth 5Y20.04%
Sales Q2Q%-4.05%

3.2 Future

The Earnings Per Share is expected to grow by 20.68% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.33% on average over the next years.
EPS Next Y3.68%
EPS Next 2Y20.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.78%
Revenue Next 2Y3.33%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XPER Yearly Revenue VS EstimatesXPER Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
XPER Yearly EPS VS EstimatesXPER Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

XPER is valuated cheaply with a Price/Earnings ratio of 6.61.
Based on the Price/Earnings ratio, XPER is valued cheaply inside the industry as 95.41% of the companies are valued more expensively.
XPER is valuated cheaply when we compare the Price/Earnings ratio to 26.43, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 5.52, the valuation of XPER can be described as very cheap.
Based on the Price/Forward Earnings ratio, XPER is valued cheaper than 97.17% of the companies in the same industry.
XPER's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.17.
Industry RankSector Rank
PE 6.61
Fwd PE 5.52
XPER Price Earnings VS Forward Price EarningsXPER Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XPER Per share dataXPER EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as XPER's earnings are expected to grow with 20.68% in the coming years.
PEG (NY)1.8
PEG (5Y)N/A
EPS Next 2Y20.68%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

XPER does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XPERI INC

NYSE:XPER (6/5/2025, 12:03:50 PM)

7.805

-0.06 (-0.7%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners91.55%
Inst Owner Change2.09%
Ins Owners2.11%
Ins Owner Change13.84%
Market Cap356.61M
Analysts84
Price Target18.61 (138.44%)
Short Float %3.77%
Short Ratio4.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)338.09%
Min EPS beat(2)63.17%
Max EPS beat(2)613.01%
EPS beat(4)3
Avg EPS beat(4)205.96%
Min EPS beat(4)-33.78%
Max EPS beat(4)613.01%
EPS beat(8)7
Avg EPS beat(8)129.66%
EPS beat(12)11
Avg EPS beat(12)111.25%
EPS beat(16)14
Avg EPS beat(16)91.5%
Revenue beat(2)0
Avg Revenue beat(2)-2.22%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-1.28%
Revenue beat(4)0
Avg Revenue beat(4)-3.77%
Min Revenue beat(4)-10.31%
Max Revenue beat(4)-0.34%
Revenue beat(8)0
Avg Revenue beat(8)-3.33%
Revenue beat(12)1
Avg Revenue beat(12)-6.41%
Revenue beat(16)1
Avg Revenue beat(16)-16.57%
PT rev (1m)0%
PT rev (3m)-2.67%
EPS NQ rev (1m)-15.02%
EPS NQ rev (3m)-33.45%
EPS NY rev (1m)9.8%
EPS NY rev (3m)4.56%
Revenue NQ rev (1m)-1.37%
Revenue NQ rev (3m)-4.09%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-2.65%
Valuation
Industry RankSector Rank
PE 6.61
Fwd PE 5.52
P/S 0.73
P/FCF N/A
P/OCF N/A
P/B 0.85
P/tB 1.35
EV/EBITDA N/A
EPS(TTM)1.18
EY15.12%
EPS(NY)1.41
Fwd EY18.1%
FCF(TTM)-0.97
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS10.7
BVpS9.17
TBVpS5.8
PEG (NY)1.8
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.04%
ROE -4.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.76%
FCFM N/A
ROA(3y)-41.72%
ROA(5y)-29.98%
ROE(3y)-66.84%
ROE(5y)-46.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y-4.34%
F-Score4
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.87%
Cap/Sales 3.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.27
Quick Ratio 2.26
Altman-Z -0.2
F-Score4
WACC11.13%
ROIC/WACCN/A
Cap/Depr(3y)21.67%
Cap/Depr(5y)15.65%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1172.73%
EPS 3Y-21.82%
EPS 5Y-21.24%
EPS Q2Q%420%
EPS Next Y3.68%
EPS Next 2Y20.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.77%
Revenue growth 3Y0.49%
Revenue growth 5Y20.04%
Sales Q2Q%-4.05%
Revenue Next Year-1.78%
Revenue Next 2Y3.33%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year743.63%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.71%
OCF growth 3YN/A
OCF growth 5YN/A